Delivery Order SPE2DR25D2005-SPE2DR26FE7V9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,373.29 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order was executed on December 2, 2025, with an ultimate completion date of December 3, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Nalbuphine is an opioid analgesic used for pain management in military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nalbuphine 10ML in quantities of 25 units, with a ceiling value of $2,460.64. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 20, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,230.32 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 10ML in quantities of 25 units. This firm fixed price, non-set-aside contract was awarded on November 25, 2025, with an ultimate completion date of the same date. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. Nalbuphine is an opioid analgesic commonly used in military and federal healthcare...
- The Defense Logistics Agency awarded a $5,569.18 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Nalbuphine 200 mg/10 mL vials. This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of October 31, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Nalbuphine is an opioid analgesic commonly used in military and federal healthcare settings for pain...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.80 firm fixed-price delivery order is for the supply of 4567767272 ! NALBUPHINE 200 MG/10 ML VIAL 10ML, with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,010.49 for naloxone hydrochloride on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,036.86 for the supply of NALBUPHINE 100 MG/10 ML VIAL 10ML. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 18, 2025, with a completion date of February 19, 2025. This contract represents a small portion of Amerisourcebergen's broader contracting relationship with the federal government, as the company...
- The Defense Logistics Agency awarded a $6,334 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/10 ml vials of nalbuphine hydrochloride. As the prime contractor, Amerisourcebergen will deliver 10 ml vials of the analgesic drug to a location in Conshohocken, Pennsylvania by July 11, 2023 to support Defense Logistics Agency requirements. The delivery order was issued under an existing DLA pharmaceuticals contract vehicle but did not have any set aside designations....
- The Defense Logistics Agency awarded a $1,824.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/10 ml vials of nalbuphine hydrochloride. The single delivery order is to be performed by Amerisourcebergen's Conshohocken, Pennsylvania facility between July 10-11, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,558.95 firm fixed-price delivery order contract is for the supply of NALBUPHINE 20 MG/ML AMPULML, a pharmaceutical product. The contract has a period of performance through February 20, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7V9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,845.48 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 ml vials on December 2, 2025, with an ultimate completion date of December 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for federal military and veteran healthcare systems through its extensive portfolio of medical product deliveries. The DLA Troop Support Medical contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceuticals and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. This delivery order for Nalbuphine, a pain management pharmaceutical, exemplifies the company's role in fulfilling federal medical supply needs through the flexible and comprehensive contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/1/25 |